Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2016 Jul 28;11(7):e0160056. doi: 10.1371/journal.pone.0160056

Differences in Facial Emotion Recognition between First Episode Psychosis, Borderline Personality Disorder and Healthy Controls

Ana Catalan 1,2,*, Maider Gonzalez de Artaza 1, Sonia Bustamante 1,2, Pablo Orgaz 2, Luis Osa 2, Virxinia Angosto 2, Cristina Valverde 2, Amaia Bilbao 3, Arantza Madrazo 2, Jim van Os 4,5, Miguel Angel Gonzalez-Torres 1,2
Editor: Christian Schmahl6
PMCID: PMC4965014  PMID: 27467692

Abstract

Background

Facial emotion recognition (FER) is essential to guide social functioning and behaviour for interpersonal communication. FER may be altered in severe mental illness such as in psychosis and in borderline personality disorder patients. However, it is unclear if these FER alterations are specifically related to psychosis. Awareness of FER alterations may be useful in clinical settings to improve treatment strategies. The aim of our study was to examine FER in patients with severe mental disorder and their relation with psychotic symptomatology.

Materials and Methods

Socio-demographic and clinical variables were collected. Alterations on emotion recognition were assessed in 3 groups: patients with first episode psychosis (FEP) (n = 64), borderline personality patients (BPD) (n = 37) and healthy controls (n = 137), using the Degraded Facial Affect Recognition Task. The Positive and Negative Syndrome Scale, Structured Interview for Schizotypy Revised and Community Assessment of Psychic Experiences scales were used to assess positive psychotic symptoms. WAIS III subtests were used to assess IQ.

Results

Kruskal-Wallis analysis showed a significant difference between groups on the FER of neutral faces score between FEP, BPD patients and controls and between FEP patients and controls in angry face recognition. No significant differences were found between groups in the fear or happy conditions. There was a significant difference between groups in the attribution of negative emotion to happy faces. BPD and FEP groups had a much higher tendency to recognize happy faces as negatives. There was no association with the different symptom domains in either group.

Conclusions

FEP and BPD patients have problems in recognizing neutral faces more frequently than controls. Moreover, patients tend to over-report negative emotions in recognition of happy faces. Although no relation between psychotic symptoms and FER alterations was found, these deficits could contribute to a patient’s misinterpretations in daily life.

Introduction

Facial emotion recognition (FER) is the capacity to interpret the emotions of others based on facial expressions [1]. FER is considered crucial for non-verbal communication and for social functioning [2]. Emotion detection task involves the identification of an emotional stimulus without specifically labelling the affective state [3,4] and is considered a key component of non-verbal communication.

Individuals with schizophrenia have problems in the perception of emotional states throughout the disorder [5]. Emotion processing alterations in patients diagnosed with schizophrenia, assessed using FER tasks, are associated with poorer community functioning [6], decreased ability to live independently and inadequate function at work [7], and decreased interpersonal skills [8]. Schizophrenia may be related to a more specific disturbance in the procedure of a set of negative emotions including anger, disgust, sadness and/or fear [9]. If these alterations are present in patients in remission as well as in patients in the acute phase of illness [10], they may represent a trait rather than a state related to psychosis. In an attempt to clarify this question, attention has focused on social cognition skills in those suffering a first episode of psychosis (FEP), and in recent times in groups “at risk” of psychosis. Several studies have repeatedly reported social cognitive impairments in FEP [11] and “at risk” populations [12]. Furthermore, a number of studies did not find differences in the alterations between patients experiencing a FEP and those in a later stage of the disorder [6,13]. Alterations in FER may thus represent a possible endophenotype related to genetic risk and the development of psychosis [14].

Given the fact that psychotic symptoms occur transdiagnostically [15], it may be productive to study FER in relation to subclinical psychotic experiences in other diagnostic groups. For example, FER alterations have been associated with various clinical variables in bipolar disorder [16], alcoholism and substance abuse [17], depression [18] and posttraumatic stress disorder [19].

Likewise, borderline personality disorder (BPD) is associated with trait elevation of psychotic symptoms. About 20–50% of patients with BPD experience psychotic symptoms (hallucinations and paranoid ideation) comparable to those in patients with psychosis from a point of view of the phenomenology, emotional meaning and their maintenance [20]. BPD patients consequently may constitute an interesting group for comprehension of cognitive processes related to the development of delusions. In addition, there is substantial evidence to support the fact that BPD patients frequently interpret ambiguous or neutral facial expressions as negative [21,22].

The purpose of the present study was twofold. First, we wished to compare possible FER alterations in a sample of FEP and BPD patients in comparison with a group of healthy controls (HC) and to examine to what degree FER alterations in patients is valence-specific, or restricted to particular emotions. To determine this, we first compared a group of FEP and BPD patients with HC for their capacity to precisely recognize facial expressions of the essential emotions. Second, we investigated associations between FER and positive, negative, depressive and disorganized symptoms in these 3 groups.

Materials and Methods

Ethics Statement

The local ethics committee (Ethics Committee of Clinical Research of Basurto University Hospital) authorized the study design. We obtained written consent from all patients of the study.

Sample

The recruitment procedures for this study were described previously [23]. Data were obtained from a convenience sample of patients with a FEP, admitted consecutively to the inpatient unit of Basurto University Hospital (HUB) from January 2010 to December 2014. BPD patients were enlisted at the Day Hospital of HUB and AMSA Clinic. HC were recruited from the general population in the same catchment area as the patients, through announcements. Controls did not report first-degree relatives with a psychotic disorder. Inclusion criteria were the following (for the three groups): age between 18 and 60 years, adequate capacity of speaking and understanding Spanish language; for FEP patients: treatment with antipsychotic medication < 1 year. The psychotic episode fulfilled DSM-IV-TR criteria for affective or non-affective psychotic disorder; for BPD patients: meeting DSM-IV-TR criteria for BPD in the absence of current psychotic disorder comorbidity (two of the patients had previous history of psychotic symptoms). Exclusion criteria for three groups were (a) current or past comorbid diagnosis of any neurological disorder which could prevent neuropsychological task performance, (b) history of severe head injury, (c) current severe medical conditions, (d) any current drug dependence and (e) unwillingness to participate.

Socio-demographic and clinical variables collected in the sample have been detailed in a previous paper [23].

Instruments

Degraded Facial Affect Recognition Task (DFAR) [24] shows images of 4 different actors (2 male and 2 female) representing the 4 emotions: angry, happy, fearful, and neutral. The task consists of 64 items made up of 16 face presentations in each emotion category. The emotions are shown with 100% and 75% intensity to increment the difficulty of the task. Subjects have to press a button when they have recognized the emotion. Results are the proportion correctly recognized as neutral, happy, fearful, and angry emotions and the overall proportion correct. This test is programmed using E-Prime software [25].

The Benton Facial Recognition Test (BFRT) [26], is a measure of the ability to match non-emotional, unfamiliar faces. This task was used to rule out subjects scoring insufficiently on general facial recognition skill.

IQ: The short form of the Wechsler Adult Intelligence Scale (WAIS)–III [27] was administered for an indication of intellectual functioning (IQ), and included the following tests: ‘Block Design’, ‘Digit Symbol’, ‘Arithmetic’ and ‘Information’.

The Positive and Negative Syndrome Scale (PANSS) [28] was used to assess symptoms in patients. This scale contains one positive symptom subscale, one negative symptom subscale and one subscale of general psychopathology. Each item can be rated from 1 (absent) to 7 (extreme). A specific model has been formulated for the social cognitive on the basis of disorganized symptoms [29]. Research to date suggests a strong association between poor mental state attribution and disorganization symptoms [30]. Van der Gaag et al. [31] developed a more fine-grained model of symptoms. This model also captures disorganized symptoms. The positive, negative, and disorganized symptom factors of the Van der Gaag model were used in our analyses.

Structured Interview for Schizotypy—Revised (SIS-R) [32] was administered to assess subclinical psychotic symptoms in controls. It is a semi-structured interview that contains 20 schizotypal symptoms and 11 schizotypal signs. We reduced the item scores to the 3 dimensions of (1) positive (referential thinking, magical ideation, illusions, and suspiciousness), (2) negative (social isolation, social anxiety, introversion, and restricted affect), and (3) disorganization schizotypy (goal directness of thinking, loosening of associations, and oddness) [29].

The Community Assessment of Psychic Experiences (CAPE) [33] was used to assess positive, negative and depressive symptoms along a frequency scale (1 = never to 4 = nearly always) and a distress scale (1 = not distressed to 4 = very distressed) in the HC and BPD groups. The mean CAPE positive, negative and depressive score was the mean of the positive, negative and depressive symptom frequency scale, respectively.

Analyses

In order to decrease differences between groups in IQ, we performed post-hoc analyses excluding from sample all subjects with IQ <70 (N = 8) and healthy controls with very high IQ (>130, N = 11). We have included analysis in whole sample as additional material (S1S4 Tables).

The descriptive statistical analysis was based on frequency tables, and means and standard deviations (SDs). The Kolmogorov-Smirnov test was used to test for deviation from normality. ANOVA with Scheffe’s method for multiple comparisons was used to examine differences between the three groups in continuous variables, and Kruskal-Wallis test was used for non-normally distributed variables. For the comparison of categorical variables, chi-square tests, and Fisher´s exact test, when indicated, were performed.

In order to analyse differences between groups in emotion recognition and to compare the type of misinterpretation during FER among the three groups, the ANOVA with Scheffe’s test for multiple comparisons or the non-parametric Kruskal Wallis test was used. Further on, the general linear model was used to analyse the differences in emotion recognition and type of misinterpretation during FER between the three groups adjusting for WAIS, age and sex.

We carried out transversal within-group analyses. Associations between emotion recognition and symptom domain was analysed using the Spearman correlation coefficient.

Statistical analyses were carried out with STATA version 12 [34].

Results

Descriptives

64 FEP, 37 BPD and 137 controls were assessed at baseline. Subjects with Benton test scores of less than 41 were excluded due to insufficient general facial recognition ability.

Socio-demographic characteristics are shown in Table 1. CAPE data were missing for three BPD patients. Diagnoses in the FEP group were: schizophrenia or schizophreniform disorder (n = 32), affective psychosis (n = 18), brief psychotic episode (n = 7) and delusional disorder (n = 7). All FEP patients were under antipsychotic medication at the time of the assessment. BPD patients were under psychopharmacologic treatment as well. Clinical variables are summarized in Table 2.

Table 1. Socio-demographic variables.

Variable FEP patients (n = 64) BPD patients (n = 37) Controls (n = 137)
Age, mean (SD) 35.5 (12.9) 36.8 (10.3) 33.1 (11.4)
Gender, n (%)*
    Male 41 (64.1%) 12 (33.3%) 77 (56.2%)
    Female 23 (35.9%) 24 (66.7%) 60 (43.8%)
Education years, mean (SD)* 15.5 (3.2) 16.7 (2.7) 17.7 (2.5)
Partnership status, n (%)*
    Single 39 (60.9%) 21 (60%) 76 (55.5%)
    Married/stable partnership 17 (26.6%) 10 (28.6%) 58 (42.3%)
    Divorced/separated 6 (9.4%) 4 (11.4%) 3 (2.2%)
    Widowed 2 (3.1%) 0 (0%) 0 (0%)
Housing, n (%)*
    With original family 35 (54.7%) 15 (42.9%) 58 (42.3%)
    With own family 18 (28.1%) 12 (34.3%) 69 (50.4%)
    Alone 11 (17.2%) 8 (22.9%) 10 (7.3%)
Employment status, n (%)**
    Full-time employment 31 (48.4%) 6 (17.1%) 78 (56.9%)
    Unemployed 26 (40.6%) 25 (71.4%) 18 (13.1%)
    Student 5 (7.8%) 1 (2.9%) 36 (26.3%)
    Retired 2 (3.1%) 0 (0%) 2 (1.5%)
    Other 0 (0%) 3 (8.6%) 3 (2.2%)
IQ, mean (SD)** 95.3 (14.4) 93.6 (12.5) 108.5 (12.7)

*p< 0.05

**p<0.0001

Table 2. Clinical variables.

FEP patients (n = 64) BPD patients (n = 37) Controls (n = 137)
mean (SD) mean (SD) mean (SD)
PANSS positive symptoms 20.3 (6)
PANSS negative symptoms 12.2 (8.5)
PANSS disorganized 10.9 (4)
GAF score 56.5 (17.7)
CAPE positive 11.5 (7.6) 4 (2.7)
CAPE negative 15.2 (7.8) 6.5 (4.1)
CAPE depressive 12.4 (5.9) 4.7 (2.4)
SIS-R positive 1.6 (1.7)
SIS-R negative 1.6 (1.3)
SIS-R disorganized 0.01 (0.1)

Emotion Recognition

A significant difference between patient groups and HC on neutral face scores was found, as well as a difference on anger scores between HC and FEP patients. No significant differences were found between groups in the fear or happy conditions (Table 3). In general terms, patients with FEP and BPD displayed a lower ability in recognizing neutral faces. These results held true after adjusting for IQ, age and sex.

Table 3. Comparison of the percentage of correct answers for emotion recognition in FEP, BPD and HC.

Unadjusted and adjusted analyses.

Unadjusted analyses
Emotion recognition FEPa (N = 64) BPDb (N = 37) HCc (N = 137) Kruskal-Wallis test
mean (SD) mean (SD) mean (SD) χ2(df = 2) p-value
Neutral 78.3 (16.6)c 74.2 (14.4)c 83.9 (11.7)a,b 14.52 0.0007
Happiness 88.4 (11.5) 86.5 (13.5) 90.4 (9.7) 2.61 0.2709
Fear 50.7 (20.1) 56.1 (17.4) 53 (19.5) 1.96 0.3758
Anger 58.5 (22.2)c 65.2 (21.2) 68.1 (21.3)a 8.29 0.0158
Recognition 69 (11.5)c 70.5 (10.4) 73.8 (9.7)a 11.81 0.0027
Adjusted analyses*
Emotion recognition FEP (N = 64) BPD (N = 37) HC (N = 137) p-value
β β β FEP vs. HC BPD vs. HC
Neutral -4.89 -8.48 Ref. 0.0343 0.0027
Happiness -1.53 -3.48 Ref. 0.4012 0.1174
Fear -0.26 3.48 Ref. 0.9347 0.3744
Anger -8.84 -2.06 Ref. 0.0152 0.6406
Recognition -3.88 -2.63 Ref. 0.0249 0.2092

a,b,c Superscript letters indicate significant differences among groups by Scheffe test for multiple comparison.

* Comparison of the percentage of correct answers for emotion recognition between groups adjusting for WAIS, age and sex by means of the general linear models.

SD: standard deviation; df: degrees of freedom; β: beta parameter estimated from the general linear model, considering the healthy controls (HC) as reference group; Ref: Reference group.

Errors in FER Answers

BPD y FEP groups had a much higher tendency to recognize negative emotions in happy faces. And BPD group had higher tendency to recognize also negative emotions in neutral faces as well. Moreover, after adjusting for other variables (IQ, sex and age), results remained significant (Table 4).

Table 4. Comparison of the percentage of subjects’ attribution when they failed in FEP, BPD and HC.

Unadjusted and adjusted analyses.

Unadjusted analyses
FEPa (n = 64) BPDb (n = 37) HCc (n = 137) Kruskal-Wallis test
mean (SD) mean (SD) mean (SD) χ2(df = 2) p-value
Neutral
    Happiness 10.7 (10.4) 12.4 (11.6) 10.9 (10.7) 0.57 0.7530
    Negative valence 6.9 (8.5) 10.5 (10.5)c 5.7 (7.6)b 7.18 0.0276
Happiness
    Neutral 5.9 (7.1) 6.8 (7.5) 7.6 (7.8) 2.14 0.3439
    Negative valence 3.3 (5.6)c 4 (7)c 1.5 (3.8)a,b 12.87 0.0016
Fear
    Neutral 33.3 (13.5)c 34.4 (15) 40.3 (15.1)a 11.42 0.0033
    Happiness 3.6 (7.4)c 2.1 (3.3) 1.4 (3.3)a 10.95 0.0042
    Anger 4.2 (6.6) 3 (5) 4.3 (6.2) 0.99 0.6097
Anger
    Neutral 18.4 (13.2) 12.9 (10) 16.9 (13.2) 3.84 0.1465
    Happiness 2.8 (4.5) 3.3 (4.8) 3 (5.6) 1.07 0.5848
    Fear 10.8 (10.3) 10.6 (10.9) 8.5 (10.4) 4.91 0.0858
Adjusted analyses*
FEP (N = 64) BPD (N = 37) HC (N = 137) p-value
β β β FEP vs. HC BPD vs. HC
Neutral
    Happiness 0.92 2.70 Ref. 0.6096 0.2200
    Negative valence 0.53 3.47 Ref. 0.6856 0.0405
Happiness
    Neutral -1.60 -0.74 Ref. 0.2122 0.6363
    Negative valence 1.61 2.18 Ref. 0.0494 0.0288
Fear
    Neutral -6.44 -4.41 Ref. 0.0097 0.1440
    Happiness 2.10 0.73 Ref. 0.0094 0.4561
    Anger -0.92 -1.93 Ref. 0.3693 0.1249
Anger
    Neutral 0.96 -4.02 Ref. 0.6555 0.1274
    Happiness -0.64 0.07 Ref. 0.4642 0.9490
    Fear 3.44 1.93 Ref. 0.0440 0.3513

a,b,c Superscript letters indicate significant differences among groups by Scheffe test for multiple comparison.

* Comparison of the percentage of correct answers for emotion recognition between groups adjusting for WAIS, age and sex by means of the general linear models.

SD: standard deviation; df: degrees of freedom; β: beta parameter estimated from the general linear model, considering the healthy controls (HC) as reference group; Ref: Reference group.

FEP patients showed a significant tendency to recognize fear faces as neutral or happy.

Association between Emotion Recognition and Symptom Domains

There was no significant association between emotion recognition and any of the different symptom domains in either patient group (correlation coefficients ranging from -0.23 to 0.22).

Discussion

FER alterations have been reported for various mental disorders and may predict poor social functioning. What remains unclear is how specific these alterations are and if certain patterns characterize particular patient groups. This study examined disorder-specific emotional alterations in two groups of patients in a comparison with HC.

There were three main findings. First, our results showed poorer emotion recognition of neutral and angry faces in FEP and of neutral faces in BPD patients. Second, these alterations were not associated with (subthreshold) psychopathology. And finally, both patient groups tended to attribute emotional negative valence more frequently than HC to happy faces. Within the three groups, the level of positive symptoms was not associated with FER alterations. These FER alterations may be more prevalent in disorders with psychosis proneness rather than being associated to specific symptoms. This may imply that FER may be more a trait of psychosis rather than a state. However, it is possible that the statistical power of sample was not enough to detect such differences (maybe due to the low number of subjects, especially in the BPD group).

Nonetheless, this study demonstrates that patients who are prone to psychosis (BPD), process emotions similarly to patients with psychosis (FEP). These findings may serve to support the hypothesis that such biases are related to interpersonal disability of these patients observed clinically, although hardly any study found a relation between emotion recognition and social functioning in the daily life of psychotic patients [35]. We have described previously that FEP and BPD patients can share other cognitive biases, such as data gathering bias that may contribute to the formation of delusions [23].

Facial Emotion Recognition Alterations

It is also still unclear whether deficits in facial emotion identification in people with psychosis are general or valence specific. Although one of the most consistent findings across studies are deficits on negative emotions (fear, disgust, sadness and anger) [14,36,37]; in our study, FEP patients only demonstrated poor recognition of angry faces, but not on fear emotion. In general terms, angry faces are more difficult to recognize [38] and this could be a possible explanation. However, this deficit is not enough to confirm our hypothesis about valence-specific deficit recognition. More relevant it seems the difficulty of recognizing neutral faces, such as other authors have described [39]. In the case of BPD patients, there is considerable experimental evidence to support the conclusion that ambiguous or neutral facial expressions are more likely to be interpreted negatively [21,22,4043].

Our results indicate a worse FER in FEP and BPD patients, especially of neutral faces, and additionally of angry faces in psychotic patients. In general terms, we could state that there was poorer affect recognition of facial emotions on neutral emotion independently of cognitive performance in both groups of patients. These results suggest that patients with severe mental disorders display alterations in general emotion recognition.

Moreover, happy faces were interpreted as negative in both groups at much higher frequencies than in HC. This tendency was also significant for neutral faces in BPD group. Hence, the ability of deducing emotional states from others may be compromised in these patients [6]. Other studies documented that BPD patients present a tendency to over-report fear when they see a neutral facial expression [43]. Similarly, in the current study, BPD patients tend to interpret fear in happy and neutral faces more frequently than HC.

In general terms, until now the reported findings do not make it clear whether the impairment is selective for concrete emotions, is selected for valence, or affects the whole domain of basic emotions. In this study, there was a clear alteration in FER in BPD patients in the recognition of neutral emotion as well as a negative misinterpretation of happy faces in both patient groups.

Other authors [5,44,45] found a specific alteration for fear and sadness, but not for disgust and anger in psychotic patients. Additionally, Comparelli et al. [5] did not find any evidence of progression or improvement over the 3 phases of psychotic process (prodromal, FEP and multi episode psychosis). This finding is in agreement with the results of other authors [46], who recently showed, in a longitudinal study, absence of progression of FER alterations from the prodromal to the post-onset period, suggesting that FER represents a vulnerability trait for developing psychotic symptoms. We found a difficulty to recognize neutral and anger condition in FEP group. And as we have described, some of these FER alterations also appear in patients who are prone to psychosis (BPD patients).

Our results indicate an alteration in recognition specifically of neutral faces in both groups, which could lead to perceive neutral emotions as negative and this can influence social interactions. Alterations in emotion recognition, although perhaps to a lesser degree, may cause negative misinterpretations of social-emotional situations. And misperceptions may lead to the avoidance of social situations or contacts and lead to problematic social behaviour.

Facial Emotion Recognition Alterations and Psychopathology

To study the nature of the associations between symptoms and social cognitive impairment in patients and HC, we performed a cross-trait within-group analysis. We did not find any association between symptom domains and FER alterations in FEP. The analyses also failed to reveal significant associations between symptom domains and psychopathology measures in BPD or HC.

A previous study suggested an association between disorganized and negative symptoms and social cognitive performance in patients diagnosed with a psychotic disorder and, to a lesser extent, subclinical negative symptoms in siblings of patients diagnosed with a psychotic disorder [47]. The lack of replication of previous findings indicates that more research is required before more definitive conclusions can be reached.

Strengths and Limitations

To the best of our knowledge, this is the first study to compare FER alterations in FEP and BPD patients in a comparison with HC. Studying individuals with FEP helps to minimize the influence of variables such as institutionalization, the long-term effects of antipsychotics and social deterioration, and could avoid variability due to the course of the illness [48].

Our results are independent of IQ performance. This is consequent with the fact that performance on social intelligence tasks is not strongly influenced by IQ [49]; emotion recognition in psychosis may be a different cognitive aspect only modestly influenced by other cognitive skills.

BPD patients commonly suffer from other psychiatric comorbidities such as depression, PTSD or drug abuse. These disorders also relate with FER alterations. The possible effects of these comorbidities need to be taken into account as well [50]. Although patients with BPD frequently present other diagnoses that are clinically important, they are not crucial to the diagnosis of BPD itself. Thus, although a complete understanding of emotion perception in BPD would be better in a sample without these comorbid disorders, we have not included comorbidity of BPD in analyses due to the low number of patients in that group.

Another limitation of the study is that we did not examine possible effects of psychotropic medication on emotion recognition. Although there have been a few studies reporting mild effects of psychoactive medication on FER [51], the recent literature reports no significant impact of antipsychotic [52] or antidepressant medication [53] on emotion recognition.

Divergences among previous studies with respect to the accuracy of FER alterations may have been the consequence of several factors including the use of different stimulus materials (e.g. Ekman versus another set of stimuli, inclusion versus exclusion of neutral faces), differences in the intensity of the emotional expression, time limits and task instructions [54]. As Fertuck [55] et al. observe, previous studies were not uniform in the selection of potentially confounding factors such as educational level, source of patient recruitment (inpatient versus outpatient), comorbidity, psychotropic medication, and state levels of psychopathology, all of which may influence emotion and mental state evaluation.

In conclusion, FER is impaired in FEP and BPD patients, especially for neutral and angry faces. Moreover, patients tend to over-report negative emotions in happy faces. Alterations appear not only in FEP, but also in BPD, suggesting that discrepancies in the processing of integrated facial emotions may be related to transdiagnostic interpersonal hostility, and social functioning. This may suggest that differences in the patients’ higher order integration of emotional perceptions may be associated with the large variation in interpersonal dysfunction observed clinically.

Supporting Information

S1 Table. Socio-demographic variables.

(PDF)

S2 Table. Clinical variables.

(PDF)

S3 Table. Comparison of the percentage of correct answer of emotion recognition in FEP, BPD and HC.

Unadjusted and adjusted analyses.

(PDF)

S4 Table. Comparison of the percentage of subjects’ attribution when they failed in FEP, BPD and HC.

(PDF)

Acknowledgments

we would like to thank to the staff of the Psychiatry Service of Basurto University Hospital for their collaboration on this project.

Data Availability

Data are available upon request in accordance with the requirements of the data protection law of the Basque Autonomous Community (Resolución de 21 de julio de 2005, del Director de la Agencia Vasca de Protección de Datos, por la que se establecen los modelos normalizados y los medios por los que debe procederse a la solicitud de las inscripciones de creación, modificación o supresión de ficheros en el Registro de Protección de Datos de la Agencia Vasca de Protección de Datos). CEIC Comité Ético de Investigación Clínica de Euskadi (Ethic Committee of Clinical Research from Euskadi) Address: Avda. Montevideo, 18. 48013 Bilbao Contact: Izaskun Basurto Telephone: +34 94 400 63 09 Fax: +34 94 400 63 06 Email: izaskun.basurtoneira@osakidetza.eus Web: www.osakidetza.euskadi.net/r85-ghhbas00/es

Funding Statement

"The authors received no specific funding for this work."

References

  • 1.Ekman P. Facial expression and emotion. Am Psychol. 1993; 48: 384–392. [DOI] [PubMed] [Google Scholar]
  • 2.Blair R. Facial expressions, their communicatory functions and neuro cognitive substrates. Phil Trans Royal Soc London B Biol Sci. 2003; 358: 561–572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schulze L, Domes G, Koppen D, Herpertz SC. Enhanced detection of emotional facial expressions in borderline personality disorder. Psychopathology. 2013; 46: 217–224. 10.1159/000341730 [DOI] [PubMed] [Google Scholar]
  • 4.Derntl B, Finkelmeyer A, Toyqar TK, Hülsmann A, Schneider F, Falkenberg DI, et al. Generalized deficit in all core components of empathy in schizophrenia. Schizophr Res. 2009; 108: 197–206. 10.1016/j.schres.2008.11.009 [DOI] [PubMed] [Google Scholar]
  • 5.Comparelli A, Corigliano V, De Carolis A, Mancinelli I, Trovini G, Ottavi G, et al. Emotion recognition impairment is present early and is stable throughout the course of schizophrenia. Schizophr Res. 2013; 143: 65–69. 10.1016/j.schres.2012.11.005 [DOI] [PubMed] [Google Scholar]
  • 6.Addington J, Saeedi H, Addington D. Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res. 2006; 85: 142–150. [DOI] [PubMed] [Google Scholar]
  • 7.Kee KS, Green MF, Mintz J, Brekke JS. Is emotion processing a predictor of functional outcome in schizophrenia?. Schizophr Bull. 2003; 29: 487–497. [DOI] [PubMed] [Google Scholar]
  • 8.Pinkham AE, Penn DL. Neurocognitive and socialcognitive predictors of interpersonal skill in schizophrenia. Psychiatry Res. 2006; 143: 167–178. [DOI] [PubMed] [Google Scholar]
  • 9.Kucharska-Pietura K, David AS, Masiak M, Phillips ML. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br J Psychiatry. 2005; 187: 523–528. [DOI] [PubMed] [Google Scholar]
  • 10.Janssen I, Krabbendam L, Jolles J, van Os J. Alterations in theory of mind in patients with schizophrenia and non-psychotic relatives. Acta Psychiatr Scand. 2003; 108: 110–117. [DOI] [PubMed] [Google Scholar]
  • 11.Bertrand MC, Sutton H, Achim AM, Malla AK, Lepage M. Social cognitive impairments in first episode psychosis. Schizophr Res. 2007; 95: 124–133. [DOI] [PubMed] [Google Scholar]
  • 12.Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Schlogelhofer M, Mossaheb N, et al. Emotion recognition in individuals at clinical high-risk for schizophrenia. Schizophr Bull. 2012; 38: 1030–1039. 10.1093/schbul/sbr015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pinkham AE, Penn DL, Perkins DO, Graham KA, Siegel M. Emotion perception and social skill over the course of psychosis: a comparison of individuals "at-risk" for psychosis and individuals with early and chronic schizophrenia spectrum illness. Cogn Neuropsychiatry. 2007; 12: 198–212. [DOI] [PubMed] [Google Scholar]
  • 14.Kohler CG, Walker JB, Martin EA, Healey KM, Moberg PJ. Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr Bull. 2010; 36: 1009–1019. 10.1093/schbul/sbn192 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Linscott RJ, van Os J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med. 2013; 43: 1133–1149. 10.1017/S0033291712001626 [DOI] [PubMed] [Google Scholar]
  • 16.Daros AR, Ruocco AC, Reilly JL, Harris MS, Sweeney JA. Facial emotion recognition in first-episode schizophrenia and bipolar disorder with psychosis. Schizophr Res. 2014; 153: 32–37. 10.1016/j.schres.2014.01.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kornreich C, Foisy ML, Philippot P, Dan B, Tecco J, Nöel X, et al. Impaired emotional facial expression recognition in alcoholics, opiate dependence subjects, methadone maintained subjects and mixed alcohol-opiate antecedents subjects compared with normal controls. Psychiaytry Res. 2003; 119: 251–260. [DOI] [PubMed] [Google Scholar]
  • 18.Persad SM, Polivy J. Differences between depressed and non depressed individuals in the recognition of and response to facial emotional cues. J Abnorm Psychol. 1993; 102: 358–368. [DOI] [PubMed] [Google Scholar]
  • 19.Shin LM, Wright CI, Cannistraro PA, Wedig MM, K. M, Martis B, et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 2005; 62: 273–281. [DOI] [PubMed] [Google Scholar]
  • 20.Schroeder K, Fisher H, Schäfer I. Psychotic symptoms in patients with borderline personality disorder: prevalence and clinical management. Curr Opin Psychiatry. 2013; 26: 113–119. 10.1097/YCO.0b013e32835a2ae7 [DOI] [PubMed] [Google Scholar]
  • 21.Nicol K, Pope M, Hall J. Facial emotion recognition in borderline personality: an association, with childhood experience. Psychiatry Res. 2014; 218: 256–258. 10.1016/j.psychres.2014.04.017 [DOI] [PubMed] [Google Scholar]
  • 22.Mitchell AE, Dickens GL, Picchioni MM. Facial emotion processing in borderline personality disorder: a systematic review and meta-analysis. Neuropsychol Rev. 2014; 24: 166–184. 10.1007/s11065-014-9254-9 [DOI] [PubMed] [Google Scholar]
  • 23.Catalan A, Simons CJ, Bustamante S, Olazabal N, Ruiz E, Gonzalez de Artaza M, et al. Data Gathering Bias: Trait Vulnerability to Psychotic Symptoms?. PLoS One. 2015; 10: 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.van´t Woult M, Aleman A, Kessels RPC, Laroi F, Kahn RS. Emotional processing in a non-clinical psychosis-prone sample. Schizophr Res. 2004; 68: 271–281. [DOI] [PubMed] [Google Scholar]
  • 25.E-Prime. PST (2002): Available: http://www.pstnet.com.
  • 26.Benton AL, Silvan AB, Hamsher KD, Varney NR, Spreen O (1983) Benton´s Test of Facial Recognition. New York: Oxford University Press. [Google Scholar]
  • 27.Blyler C, Gold J, Iannone V, Buchanan R. Short form of the WAIS-III for use with patients with schizophrenia. Schizophr Res. 2000; 46: 209–215. [DOI] [PubMed] [Google Scholar]
  • 28.Peralta V, Cuesta MJ. Validación de la Escala de los Síndromes Positivo y Negativo (PANSS) en una muestra de esquizofrénicos españoles. Actas Luso-ESp Neurol Psiquiatr. 1994; 22: 171–177. [PubMed] [Google Scholar]
  • 29.Hardy-Bayle MC, Sarfati Y, Passerieux C. The cognitive basis of disorganization symptomatology in schizophrenia and its clinical correlates: toward a pathogenetic approach to disorganization. Schizophr Bull. 2003; 29: 459–471. [DOI] [PubMed] [Google Scholar]
  • 30.Brune M, Schaub D, Juckel G, Langdon R. Social skills and behavioral problems in schizophrenia: the role of mental state attribution, neurocognition and clinical symptomatology. Psychiatry Res. 2011; 190: 9–17. 10.1016/j.psychres.2010.03.015 [DOI] [PubMed] [Google Scholar]
  • 31.van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross validation of a revised model. Schizophr Res. 2006; 85: 280–287. [DOI] [PubMed] [Google Scholar]
  • 32.Vollema MG, Ormel J. The reliability of the structured interview for schizotypy-revised. Schizophr Bull. 2000; 26: 619–629. [DOI] [PubMed] [Google Scholar]
  • 33.Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002; 32: 347–358. [DOI] [PubMed] [Google Scholar]
  • 34.StataCorp (2011) Stata Statistical Software: Release12. In: LP. TS, editor. version release 12 ed.
  • 35.Janssens M, Lataster T, Simons CJ, Oorschot M, Lardinois M, van Os J, et al. Emotion recognition in psychosis: no evidence for an association with real world social functioning. Schizophr Res. 2012; 142: 116–121. 10.1016/j.schres.2012.10.003 [DOI] [PubMed] [Google Scholar]
  • 36.Barkl SJ, Lah S, Harris AW, Williams LM. Facial emotion identification in early-onset and first-episode psychosis: a systematic review with meta-analysis. Schizophr Res. 2014; 159: 62–69. 10.1016/j.schres.2014.07.049 [DOI] [PubMed] [Google Scholar]
  • 37.Marwick K, Hall J. Social cognition in schizophrenia: a review of face processing. Br Med Bull. 2008; 88: 43–58. 10.1093/bmb/ldn035 [DOI] [PubMed] [Google Scholar]
  • 38.Montagne B, Kessels RPC, De Haan EH, Perrett DI. The emotion recognition task: a paradigma to measure the perception of facial emotion expressions at different intensities. Percept Mot Skills. 2007; 104: 589–598. [DOI] [PubMed] [Google Scholar]
  • 39.Kohler CG, Turner TH, Bilker WB, Brensinger CM, Siegel SJ, Kanes SJ, et al. Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry. 2003; 160: 1768–1774. [DOI] [PubMed] [Google Scholar]
  • 40.Minzenberg MJ, Poole JH, Vinogradov S. Social-emotion recognition in borderline personality disorder. Compr Psychiatry. 2006; 47: 468–474. [DOI] [PubMed] [Google Scholar]
  • 41.Bland EB, Williams CA, Scharer K, Manning S. Emotion processing in boderline personality disorders. Issues Ment Health Nurs. 2004; 25: 655–672. [DOI] [PubMed] [Google Scholar]
  • 42.Levine D, Marziali E, Hood J. Emotion processing in borderline personality disorders. J Nerv Ment Dis. 1997; 185: 240–246. [DOI] [PubMed] [Google Scholar]
  • 43.Wagner AW, Linehan MM. Facial expression recognition ability among women with borderline personality disorder: implications for emotion regulation? J Pers Disord. 1999; 13: 329–344. [DOI] [PubMed] [Google Scholar]
  • 44.Edwards J, Pattison PE, Jackson HJ, Wales RJ. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res. 2001; 48: 235–253. [DOI] [PubMed] [Google Scholar]
  • 45.Amminger GP, Schafer MR, Klier CM, Schlogelhofer M, Mossaheb N, Thompson A, et al. Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls. Early Interv Psychiatry. 2012; 6: 450–454. 10.1111/j.1751-7893.2012.00362.x [DOI] [PubMed] [Google Scholar]
  • 46.Addington J, Piskulic D, Perkins D, Woods SW, Liu L, Penn DL. Affect recognition in people at clinical high risk of psychosis. Schizophr Res. 2012; 140: 87–92. 10.1016/j.schres.2012.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Fett AK, Maat A. Social cognitive impairments and psychotic symptoms: what is the nature of their association? Schizophr Bull. 2013; 39: 77–85. 10.1093/schbul/sbr058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wozniak J, Block E, White T, Jensen J, Schulz SC. Clinical and neurocognitive course in early-onset psychosis: A longitudinal study of adolescents with schizophrenia-spectrum disorders. Early Interv Psychiatry. 2008; 2: 169–177. 10.1111/j.1751-7893.2008.00075.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Penn DL, Spaulding W, Reed D, Sullivan M, Mueser KT, Hope DA. Cognition and social functioning in schizophrenia. Psychiatry. 1997; 60: 281–291. [DOI] [PubMed] [Google Scholar]
  • 50.Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004; 161: 2108–2114. [DOI] [PubMed] [Google Scholar]
  • 51.Fu CH, Williams SC, Brammer MJ, Suckling J, Kim J, Cleare AJ, et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry. 2007; 164: 599–607. [DOI] [PubMed] [Google Scholar]
  • 52.Hempel RJ, Dekker JA, van Beveren NJ, Tulen JH, Hengeveld MW. The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review. Psychiatry Res. 2010; 178: 1–9. 10.1016/j.psychres.2008.07.025 [DOI] [PubMed] [Google Scholar]
  • 53.Tranter R, Bell D, Gutting P, Harmer C, Healy D, Anderson IM. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord. 2009; 118: 87–93. 10.1016/j.jad.2009.01.028 [DOI] [PubMed] [Google Scholar]
  • 54.Unoka Z, Fogd D, Fuzy M, Csukly G. Misreading the facial signs: specific impairments and error patterns in recognition of facial emotions with negative valence in borderline personality disorder. Psychiatry Res. 2011; 189: 419–425. 10.1016/j.psychres.2011.02.010 [DOI] [PubMed] [Google Scholar]
  • 55.Fertuck EA, Jekal A, Song I, Wyman B, Morris MC, Wilson ST, et al. Enhanced 'Reading the Mind in the Eyes' in borderline personality disorder compared to healthy controls. Psychol Med. 2009; 39: 1979–1988. 10.1017/S003329170900600X [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Socio-demographic variables.

(PDF)

S2 Table. Clinical variables.

(PDF)

S3 Table. Comparison of the percentage of correct answer of emotion recognition in FEP, BPD and HC.

Unadjusted and adjusted analyses.

(PDF)

S4 Table. Comparison of the percentage of subjects’ attribution when they failed in FEP, BPD and HC.

(PDF)

Data Availability Statement

Data are available upon request in accordance with the requirements of the data protection law of the Basque Autonomous Community (Resolución de 21 de julio de 2005, del Director de la Agencia Vasca de Protección de Datos, por la que se establecen los modelos normalizados y los medios por los que debe procederse a la solicitud de las inscripciones de creación, modificación o supresión de ficheros en el Registro de Protección de Datos de la Agencia Vasca de Protección de Datos). CEIC Comité Ético de Investigación Clínica de Euskadi (Ethic Committee of Clinical Research from Euskadi) Address: Avda. Montevideo, 18. 48013 Bilbao Contact: Izaskun Basurto Telephone: +34 94 400 63 09 Fax: +34 94 400 63 06 Email: izaskun.basurtoneira@osakidetza.eus Web: www.osakidetza.euskadi.net/r85-ghhbas00/es


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES